Table 3.

Unmatched and matched comparisons of initial and long-term costs reported as median percent of the custom approach (interquartile range).

Costs type	Unmatched			Matched
	Autologous (n = 128)	Custom (n = 32)	P value	Autologous (n = 29)	Custom (n = 29)	P value
Initial surgery costs
Other	2.1 (1.0–7.5)	1.6 (1.1–3.8)	0.42	1.6 (0.9–4.5)	1.6 (1.0–4.2)	0.97
Lab	1.0 (0.5–2.0)	1.0 (0.6–2.2)	0.55	1.2 (0.6–3.0)	0.9 (0.6–1.9)	0.37
Pharmacy	4.4 (3.2–6.7)	3.1 (2.2–5.3)	0.03	3.6 (2.2–4.8)	3.3 (2.0–6.1)	0.99
Imaging	0.2 (0.2–0.6)	0.2 (0.1–0.4)	0.18	0.2 (0.1–0.6)	0.2 (0.1–0.4)	0.78
Implant	12.2 (4.9–27.7)	89.2 (24.2–133.6)	<0.01	6.5 (4.2–26.8)	88.5 (30.7–132.5)	<0.01
Supply	2.4 (1.3–5.3)	2.7 (1.4–5.0)	0.88	2.9 (1.4–4.8)	2.9 (1.6–5.4)	0.62
Facility	24.0 (18.8–36.6)	26.0 (17.1–31.2)	0.80	21.2 (19.1–33.9)	26.1 (17.4–31.6)	0.70
Total direct	46.8 (36.0–71.1)	100.0 (76.3–131.5)	<0.01	58.3 (31.8–68.9)	100.0 (76.3–126.6)	<0.01
Initial plus long-term costs
Other	2.9 (1.2–10.2)	1.7 (1.1–4.1)	0.07	1.7 (1.0–4.9)	1.7 (1.0–4.3)	0.73
Lab	1.4 (0.6–4.1)	1.0 (0.7–2.8)	0.74	1.3 (0.7–3.0)	1.0 (0.7–2.5)	0.32
Pharmacy	12.2 (3.4–9.8)	3.2 (2.3–6.4)	<0.01	3.8 (2.3–7.0)	3.7 (2.2–6.8)	0.41
Imaging	0.3 (0.2–0.7)	0.2 (0.1–0.4)	0.04	0.3 (0.2–0.6)	0.3 (0.1–0.4)	0.41
Implant	18.5 (6.0–46.6)	89.2 (46.0–133.6)	<0.01	44.7 (5.4–112.4)	96.3 (49.6–132.1)	<0.01
Supply	3.3 (1.4–7.2)	2.8 (1.4–7.2)	0.47	2.9 (1.5–5.9)	2.9 (2.1–6.0)	0.76
Facility	29.5 (19.7–65.4)	29.4 (18.7–33.21)	0.23	26.6 (19.3–38.4)	29.9 (21.0–33.2)	0.77
Total direct	58.7 (35.5–136.8)	101.8 (78.2–133.2)	0.03	86.3 (36.5–134.8)	101.9 (78.9–125.5)	0.03

Boldface font indicates statistical significance.

Data reported as median percent (interquartile range).